Both in Pharmaceuticals
Sagimet Biosciences Inc. Series A vs Design Therapeutics
Over the past year SGMT returned +23.0% and DSGN returned +60.9%; their daily moves had a correlation of 0.31.
SGMT +23.0% DSGN +60.9%Growth of $1, one year, split-adjusted
| Metric | SGMT | DSGN |
|---|---|---|
| Price | $9.95 | $10.34 |
| Market cap | $705.5M | $647.1M |
| Today | +2.68% | +1.87% |
| 1 month | +10.2% | −16.7% |
| 6 months | +28.9% | −22.9% |
| Year to date | +68.1% | +10.2% |
| 1 year | +16.8% | +54.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $240.1M | $207.4M |
| Dividend yield | — | — |
| Volatility (60d) | 73.1% | 55.2% |
| Short % of float | 18.7% | 21.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).